Marcus Bergler

D2L is a KOL data and technology provider for the Life Sciences industry headquartered in Bangalore, India with offices in North America and Europe and has recently been recognized as one of the 25 fastest growing technology consultant companies in India by The CEO Magazine. With its KOL data, services and technology solutions D2L addresses all relevant KOL data use cases in the Life Sciences industry, from ad-hoc identification and profiling projects to enterprise KOL data implementations.

As a member of the advisory board I support the founders of the Life Sciences start-up PharmACT AG in the development of the commercialization strategy for their point of care diagnostic tests BelDIA PRE (detecting elevated intact proinsulin levels as early diabetes risk indicator) and BelCARDIO (rapid diagnostic of an acute heart attack as short as 30 min after the incident). PharmACT is looking for distributors for BelDIA PRE and BelCARDIO, please do not hesitate to get in touch with me to learn more.